The mug that predicts your memory: what tea and coffee do to your brain over decades

Richard Moore
Dec 3, 2025
26 min read

If you drink tea or coffee every day, this might be the most important thing you read for your future brain.

Most people think their daily mug is about taste, comfort, maybe a little energy boost. Yet quietly, in the background, that same mug is showing up again and again in studies of who does and does not go on to develop Alzheimer’s disease, Parkinson’s disease and other forms of dementia (and where it does nothing at all, like amyotrophic lateral sclerosis (ALS).

This is not a “coffee is magic” story or a “green tea cures dementia” story. It is stranger, more nuanced, and a lot more personal than that.

Let’s start with what the science actually shows, then walk inside your cup, your genes and your nervous system.

The big headline: your mug is quietly voting on your dementia risk

Imagine zooming out with a satellite and looking at hundreds of thousands of people from above, watching what they drink for years, then seeing who develops dementia. That is roughly what the big cohort studies and meta-analyses do.

A 2023 meta analysis of prospective cohort studies found that people who regularly drank tea, mostly green or black, had a significantly lower risk of all cause dementia, vascular dementia and Alzheimer’s disease, with risk reductions typically around 10 to 30 percent compared with non drinkers, and a pattern where each extra daily cup nudged risk a little lower within a moderate range (Jiang et al., 2023).

The United Kingdom Biobank, which follows more than 365,000 adults, reported that drinking coffee or tea on their own, or both together, was associated with a lower risk of stroke and dementia. The lowest risk appeared in people who drank about 2 to 3 cups of coffee, or 3 to 5 cups of tea, or a combined 4 to 6 cups of tea and coffee per day, with about a 28 percent lower dementia risk in those mixed drinkers compared with people who drank neither (Zhang et al., 2021). Importantly, in Zhang’s analysis the very lowest risk point still sat in the 2–3 cup range; the higher 4–6 cup combined category had lower risk than non-drinkers, but it did not show extra benefit beyond the moderate intake range. In other words, the benefit plateaued rather than increasing with higher intake.

A separate meta analysis in 2024 that pooled 29 prospective studies across several countries found that about 2 to 3 cups of coffee per day was linked to the lowest Alzheimer’s disease risk. Beyond that level, the benefit flattened and could even weaken slightly (Zhu et al., 2024; Nila et al., 2023; Liu et al., 2016). Systematic reviews that look at caffeine itself, mostly from tea and coffee, broadly support the idea that moderate intake is associated with slower cognitive decline, although not every cohort shows the same strength of effect (Chen et al., 2020).

These are not small, fragile studies. The midlife CAIDE cohort in Finland found that people who drank 3 to 5 cups of coffee per day in their forties and fifties had substantially lower later life dementia and Alzheimer’s disease risk than people who rarely drank coffee, even after adjusting for blood pressure, cholesterol, education, body weight and smoking (Eskelinen et al., 2009). Another large analysis in Norway, the HUNT study, found that patterns of coffee and tea at midlife tracked with later dementia risk as well (Abbel et al., 2023).

When you zoom in on Parkinson’s disease, the picture gets even clearer. Meta analyses consistently show that higher caffeine intake is associated with roughly 25 to 30 percent lower Parkinson’s disease risk (Costa et al., 2010; Li et al., 2012; Hong et al., 2020). Tea appears here too. A quantitative review reported that regular tea drinkers had lower Parkinson’s risk, and an Israeli case control study found that drinking more than three cups of tea per day delayed the onset of motor symptoms by almost eight years, compared with drinking less than one cup (Kandinov et al., 2009; Wu et al., 2009). In the Singapore Chinese Health Study, black tea in particular was linked to a lower Parkinson’s risk, suggesting that compounds beyond caffeine contribute (Tan et al., 2008).

Then there is Amyotrophic Lateral Sclerosis (ALS), the most common form of Motor Neurone Disease (MND). Here, coffee and tea barely move the needle. Two large pooled analyses of prospective cohorts, including more than 1,200 cases of amyotrophic lateral sclerosis, found no significant association between habitual intake of coffee, tea or total caffeine and risk of developing the disease or dying from it (Fitzgerald et al., 2014; Fondell et al., 2015). A recent review of caffeine and amyotrophic lateral sclerosis outcomes essentially concluded “no clear effect”, but also “no evidence of harm” (Huin et al., 2024).

If you step back, the broad strokes look like this:

Moderate tea and coffee intake are repeatedly linked with lower risk of dementia and Parkinson’s disease in large human studies.
ALS risk looks mostly indifferent.
None of this proves causation, but it strongly suggests that something inside these drinks travels with brain resilience over time.

To understand that “something”, we need to look inside the cup.

The secret life of your latte: caffeine, plant chemicals and your neurones

Imagine your brain as a city that never really sleeps. Neurones are the buildings, electrical signals are the traffic, brain cells that support and clean are the road teams and waste collectors. Every second, signals start, stop, slow down and accelerate.

Caffeine is the traffic light hacker.

Under normal conditions, a molecule called adenosine builds up in your brain as you stay awake. When adenosine locks onto its receptors, especially one called A2A, it sends a clear message: “Slow down, you are tired now.” Caffeine looks a lot like adenosine, so it sits in those receptors without turning them on. The “slow down” signal cannot get through, and your neurones keep firing a bit longer and a bit faster (Chen et al., 2020).

In animal and cell models of Parkinson’s disease, blocking adenosine A2A receptors does more than keep you awake. It tones down microglia, the brain’s immune cells, reduces inflammatory signalling and protects dopamine-producing neurones in the part of the brain called the substantia nigra (Costa et al., 2010; Hong et al., 2020). That is one reason caffeine is taken seriously as a potential contributor to the lower Parkinson’s risk seen in coffee and tea drinkers.

But caffeine is only one character.

Tea and coffee carry dense cargoes of polyphenols, plant-derived molecules that behave like a combination of rust remover, fire extinguisher and crowd control inside the brain.

In green tea, the lead actor is epigallocatechin 3 gallate, usually shortened to EGCG. It can cross the blood-brain barrier. In preclinical work, EGCG mops up reactive oxygen “sparks”, helps stop metals like iron and copper from driving further damage, and calms overactive microglia and astrocytes, the brain’s support cells (Pervin et al., 2018; Islam et al., 2025). It also makes it harder for problem proteins like beta amyloid and alpha synuclein to stick together into clumps, early steps in Alzheimer’s disease and Parkinson’s disease pathology. In animal models, EGCG supports the cell’s recycling systems and the mitochondria, the tiny energy factories. Small human studies suggest green tea extracts can shift some brain-related biomarkers, but we do not yet have large long-term dementia prevention trials.

Coffee has its own signature chemicals, especially chlorogenic acids. These polyphenols appear to reduce oxidative stress, improve blood vessel function and influence cholinergic signalling, which is one of the key messenger systems involved in attention and memory. A 2024 systematic review of coffee-derived chlorogenic acids reported modest acute improvements in attention and mood in humans, probably mediated by changes in cerebral blood flow, although long-term dementia outcomes were not directly tested (Johal et al., 2024).

Green tea brings another, quieter compound to the story: L-theanine. L-theanine is an amino acid analogue that increases alpha frequency brain waves, the pattern associated with calm focus. Randomised controlled trials show that when L-theanine is combined with caffeine, it can improve attention, working memory and subjective calm compared with caffeine alone (Owen et al., 2008; Kahathuduwa et al., 2020). No one has yet proven that L-theanine by itself prevents dementia, but its short-term “relaxed alertness” effect is well supported and likely contributes to the way people feel after drinking green tea or matcha compared with coffee.

So each mug is not just a jolt. It is a pharmacological blend: an adenosine blocker, a cluster of antioxidant and anti-inflammatory polyphenols and, in the case of tea, a gentle calming agent.

Over years and decades, that combination might help nudge the brain toward less oxidative damage, steadier signalling and healthier blood vessels. The evidence is suggestive, not definitive, and the honest position is that we are still joining the dots.

Coffee under the microscope: the sweet spot, the brewing trap and different diseases

It is tempting to talk about “coffee” as if it were one thing. It is not.

A single espresso, a paper-filtered pour-over, a French press and an instant coffee might all have similar caffeine, but they differ in their fats, diterpenes and polyphenol profiles.

Across several systematic reviews, the relationship between coffee and dementia risk forms a shallow U. Low to moderate coffee intake, roughly 1 to 4 cups per day, is associated with a lower risk of dementia and Alzheimer’s disease, whereas drinking more than 4 cups does not add extra protection and may gently flatten or slightly reverse the benefit (Liu et al., 2016; Nila et al., 2023; Zhu et al., 2024; Chen et al., 2020). This pattern is echoed in cohort studies such as CAIDE, HUNT and the United Kingdom Biobank, where the strongest association consistently sits in the moderate range, particularly around 2 to 3 cups per day. Higher intakes generally remain lower risk than none at all, but they do not outperform the moderate-intake sweet spot (Eskelinen et al., 2009; Abbel et al., 2023; Zhang et al., 2021).

For Parkinson’s disease, the curve looks more like a downward slope. Meta analyses and an umbrella review that pulled together dozens of studies show a fairly consistent pattern that higher caffeine intake is associated with lower Parkinson’s risk, with about 25 to 30 percent risk reduction in the higher intake categories, although the exact numbers vary by study (Costa et al., 2010; Li et al., 2012; Hong et al., 2020; Grosso et al., 2017). Some work also suggests that people with Parkinson’s disease who continue to consume caffeine may have slightly slower motor progression, but the effects are modest.

For ALS/MND, the line is almost flat. The large cohorts and pooled analyses have not found convincing evidence that more coffee, more tea or more caffeine changes who gets amyotrophic lateral sclerosis or how long they live with it (Fitzgerald et al., 2014; Fondell et al., 2015; Huin et al., 2024). Coffee simply seems neutral here.

Brewing method matters more for your heart and blood vessels than for your neurones - but because vascular health and brain health are closely connected, it’s still worth paying attention to how you make your coffee.

Unfiltered coffee - like Turkish coffee, boiled Scandinavian coffee, and many French-press styles - contains natural oily compounds called diterpenes (mainly cafestol and kahweol). You can think of them as tiny waxy molecules from the coffee bean: great for flavour and body, but in the bloodstream they signal the liver to produce more cholesterol. Recent studies show that unfiltered coffee is associated with higher LDL and total cholesterol, while filtered coffee has a much smaller effect (Svatun et al., 2022; Farraj et al., 2024). Paper-filtered coffee works differently. The filter acts like a fine sieve, catching most of these diterpenes before they reach your mug. That’s why, from the perspective of heart and blood vessel health, filtered coffee is generally considered a gentler everyday choice.

Here’s the safest, most defensible summary of current human research:

Filtered coffee in low to moderate amounts can fit comfortably into a generally healthy lifestyle for most people.

Very high intakes - especially of unfiltered coffee - can start to work against that picture, not because caffeine suddenly becomes harmful, but because of side-effects at high doses: rising cholesterol, higher blood pressure in sensitive individuals, and more anxiety or sleep disruption. These factors matter over time, particularly for long-term vascular health, which is closely linked to brain health.

When coffee stops helping: anxiety, sleep theft and the “wired but tired” nervous system

For one person, coffee is the friendly push that turns a foggy morning into a focused one. For another, it is a hand on the panic button.

Part of the difference is dose. Part is timing. Part is genetics. And part is the state your nervous system is already in.

Caffeine increases activity in the sympathetic nervous system and can raise stress hormones such as cortisol, particularly in people who are not heavy habitual consumers or when doses creep upward (Wikoff et al., 2017). In moderation, that is the “get up and go” feeling that helps you start the day. In excess, especially layered on an already high stress life, it can help keep your system in a chronic fight or flight mode, which is not an ideal baseline for a brain that you want to age calmly.

Sleep is even less forgiving. A controlled trial that gave healthy adults 400 milligrams of caffeine at various times found that even when caffeine was taken six hours before bedtime, it reduced total sleep time and sleep efficiency. Taken closer to bedtime, the effects were bigger (Drake et al., 2013). Another study has confirmed that evening high-dose caffeine fragments sleep architecture and degrades sleep quality across the night (Gardiner et al., 2025). Chronic partial sleep loss is strongly linked with worse cognition and higher Alzheimer’s disease pathology, including greater accumulation of beta amyloid. If your caffeine habit is cutting into your deep sleep, your brain does not care that you also drank some antioxidant catechins.

On the mental health side, a 2024 meta analysis reported that higher caffeine intakes are associated with higher levels of anxiety, with the steepest jump in people consuming more than about 400 milligrams per day, roughly equivalent to four standard coffees for many people (Liu et al., 2024). Experimental work in people with panic disorder shows that doses equivalent to about five cups of coffee can provoke panic attacks in a substantial proportion of participants, and can significantly raise anxiety even in otherwise healthy volunteers.

Now add genetics.

Catechol-O-methyltransferase, often shortened to COMT, is an enzyme that helps clear dopamine and noradrenaline in the prefrontal cortex. A common variant called Val158Met changes how fast this enzyme works. People with the “Met/Met” version have slower COMT activity. They carry higher baseline levels of dopamine in that part of the brain, which can mean better performance on some tasks in calm conditions, but also a tendency toward feeling overwhelmed, anxious or “too revved” when life gets stressful (Stein et al., 2006).

Small human studies suggest that when people with slow COMT activity consume higher doses of caffeine, they may experience stronger subjective stimulation and more pronounced increases in heart rate, although results are not perfectly consistent and sample sizes are still modest (Brathwaite et al., 2011). If you recognise yourself as someone who feels shaky, sweaty, restless or “not quite in your body” after what looks like a small amount of coffee on paper, your COMT and related pathways may be part of the story.

The take home is not “never drink coffee if you have a COMT single-nucleotide polymorphism”. The sensible, grounded message is that your safe window for caffeine is probably narrower, and that shifting toward green tea, matcha or smaller, earlier coffees can deliver many of the brain friendly plant compounds with less pressure on your stress system.

Your gut, your iron and the “hidden side quests” of tea and coffee

While the headlines tend to focus on dementia and Parkinson’s disease, some of the most important ways tea and coffee affect your long term brain health are indirect.

Coffee stimulates stomach acid, gastrin, bile and colonic motility. For some people, that means comfortable regularity. For others, it means acid reflux, cramps or urgent trips to the toilet. A recent review suggested that coffee drinkers may actually have a slightly lower long term risk of developing irritable bowel syndrome, but cross sectional work in people who already have irritable bowel syndrome often finds that high caffeine intakes are associated with worse symptoms, especially in women and people with higher body mass index (Lee et al., 2023). What the data really say is “often fine, clearly not fine for some”, which is why your own gut response matters more than population averages.

Both tea and coffee contain tannins that reduce the absorption of non-haem iron from plant foods when drunk with meals. Classic tracer studies show that coffee with an iron-containing meal can lower non haem iron absorption by roughly 40 percent, and that black tea can lower it by 60 to 70 percent, although waiting even one hour between drinking and eating reduces the effect dramatically (Hurrell et al., 1999; Fuzi et al., 2017). Matcha and strongly brewed green tea may be particularly powerful here, because you are consuming the whole powdered leaf.

For someone with low ferritin, heavy menstrual bleeding, a plant-based diet or a history of gut surgery or malabsorption, this is not a trivial detail. Spacing your tea, coffee and matcha away from iron-rich meals and supplements is a simple, evidence-backed way to keep enjoying your ritual without sabotaging your iron stores, which in turn affect energy, mood, cognition and hair health.

Then there is the question nobody wants to think about: contaminants.

Tea plants are metal sponges. Reviews that have pooled data from hundreds of samples show that tea leaves can accumulate metals such as lead, cadmium, arsenic and aluminium from soil and air, sometimes exceeding national limits in certain regions and types of tea (Hu et al., 2023; Fan et al., 2025). An updated review on aluminium in tea and Alzheimer’s disease concluded that tea is indeed a metal accumulator, but that even relatively high daily consumption of typical black or green tea is unlikely to reach levels that clearly raise risk of aluminium toxicity in humans (Khan et al., 2024).

For most people, choosing reputable brands, not over-concentrating the same low-quality tea leaves all day and varying what they drink keeps the real-world risk very low. Heavy metals in tea are best thought of as a background whisper, not a loud hazard siren, unless someone is drinking large amounts of cheap tea from contaminated soils. However, for those with a high metal load, no additional exposure to metal is optimal.

Tea, matcha and the “quiet upgrade” for an ageing brain

If coffee is the loud, charismatic friend who gets things moving, tea, especially green tea and matcha, are the quieter friends who help you stay, think and repair.

Tea from the plant Camellia sinensis has one of the strongest observational records for dementia protection. The 2023 meta analysis by Jiang and colleagues found that both green tea and black tea consumption were associated with significantly lower risk of all cause dementia, vascular dementia and Alzheimer’s disease (Jiang et al., 2023). A large cohort in China reported that tea drinkers had lower incident dementia, post stroke dementia and stroke, with benefits strongest around one to six cups per day rather than at very high intakes (Hu et al., 2022).

A Japanese cohort recently made headlines when it reported that people in the highest category of green tea intake, at least 600 millilitres per day, had about a 25 percent lower risk of dementia compared with those in the lowest category, and that each additional daily cup was associated with roughly a 5 percent reduction in risk within the studied range (Saji et al., 2025). Together with earlier Japanese and UK data, a consistent picture emerges: people who drink green tea regularly tend to have lower dementia rates.

Mechanistically, this lines up with what we see in the lab. EGCG and related catechins reduce oxidative stress, calm pro-inflammatory cytokines, support mitochondrial health, and interfere with the misfolding and aggregation of beta amyloid and alpha synuclein. They also seem to encourage autophagy, which is the cell’s rubbish collection and recycling system, and support synaptic plasticity, the ability of connections between neurones to strengthen or weaken as you learn (Pervin et al., 2018; Islam et al., 2025).

Matcha, which is simply powdered green tea leaves whisked into water, turns the dial up. Because you drink the leaf itself, not just a water infusion, you get higher doses of catechins, caffeine and L-theanine per cup. A 12-month randomised controlled trial in older adults with mild cognitive decline found that regular matcha consumption improved aspects of emotional perception and sleep quality, and hinted at cognitive benefits over time, although sample sizes were small and not every outcome changed (Uchida et al., 2024). Another study has suggested that daily matcha may help slow cognitive decline in community-dwelling elderly women (Kurita et al., 2020). These are not blockbuster trials, but they fit with the broader “quiet upgrade” picture.

One quiet complication in the tea story is the tea bag itself. Many of the “silky” pyramid bags marketed as premium are actually made from nylon or polyethylene terephthalate. When steeped in boiling water, several studies show they can release microplastics and nanoplastics into the cup - in some controlled experiments, billions of particles per bag (Hernandez et al., 2019). More recent analyses confirm that polymer-based bags shed plastic fragments across multiple commercial brands, though quantities vary widely (Ali et al., 2023; Banaei et al., 2024; Yousefi et al., 2024). A 2025 materials study even detected particle concentrations above 10¹¹ per litre under certain steeping conditions (Yaroslavov et al., 2025). The internal critic must say this clearly: no human studies have linked tea-bag-derived microplastics with dementia, Parkinson’s disease or amyotrophic lateral sclerosis. Cell studies show that micro- and nanoplastics can promote oxidative stress and neuroinflammatory signalling - mechanisms relevant to neurodegeneration - but real-world effects remain unknown. For anyone drinking multiple cups a day, especially from polymer bags, loose-leaf tea or plastic-free bags is a simple way to capture the cognitive benefits without the unnecessary plastic load.

Black tea starts from the same leaf but is fully oxidised, which converts catechins into theaflavins and thearubigins. These compounds still have antioxidant and vascular effects, and a 2025 review even suggests they may be particularly good at buffering heavy metal toxicity and oxidative stress (Wnuk et al., 2025). Epidemiologically, black tea appears in dementia protective cohorts too, although signals are often a little weaker than for green tea, and in Parkinson’s disease it sometimes looks stronger, as in the Singapore cohort where black tea was the star (Tan et al., 2008).

Here’s the honest reality: almost all of this tea and dementia evidence is observational. It tells us that tea drinkers tend to do better, not that tea alone is the cause. Tea drinking comes bundled with culture, social habits, and other lifestyle factors. There are even genetic studies that suggest people with variants associated with very high tea intake might have smaller hippocampal volume, which reminds us that more is not always better and that context matters.

Herbal allies: where rooibos, ginger, sage, cistus and peppermint really fit in

Once you step outside Camellia sinensis, you are no longer talking about “tea” in the classic sense. You are talking about herbal infusions. The evidence base for these is much thinner when it comes to dementia, Parkinson’s disease or ALS/MND, but that does not mean they are irrelevant.

Rooibos, made from Aspalathus linearis, is naturally caffeine-free and rich in unique polyphenols such as aspalathin. In cell and animal studies, rooibos extracts reduce oxidative stress, calm inflammatory signalling and protect neurons from toxin-induced damage, which makes it an attractive candidate as a brain-friendly drink, but we simply do not have long-term human data connecting rooibos intake to dementia risk (Pervin et al., 2018). For now, rooibos is best understood as a gentle antioxidant infusion that supports an anti-inflammatory lifestyle, not as a proven neuroprotective agent.

Cistus tea, made from Cistus incanus or rock-rose, is another under the radar herbal infusion with striking antioxidant potential. A 12 week trial in healthy adults found that regular Cistus tea reduced oxidative stress markers, including malondialdehyde, and improved aspects of the lipid profile, with higher HDL cholesterol and lower triglycerides (Skalska et al., 2021). More recent analyses place Cistus teas among the most antioxidant rich herbal infusions tested, with dense polyphenol and ellagitannin content driving strong free radical scavenging and anti-inflammatory activity (Cendrowski et al., 2023; Oniszczuk et al., 2023; Djavaheri-Mergny et al., 2025). None of these studies looked directly at dementia, Parkinson’s disease or ALS/MND, so it cannot be sold as a neuroprotective treatment. But because oxidative stress and chronic inflammation sit at the heart of early neurodegenerative biology, Cistus makes sense as a caffeine-free “terrain support” tea: a way to gently nourish the wider environment in which long-term brain health is built, rather than a disease-specific intervention.

Ginger is mainly a gut story. Randomised controlled trials show that ginger can improve functional dyspepsia symptoms, help gastric emptying and reduce nausea, likely by affecting serotonin receptors and motility (Giacosa et al., 2015; Aregawi et al., 2023). Ginger also stimulates saliva and swallowing reflexes in some formulations, which makes ginger with lemon and ginger with sage plausible combinations for people who struggle with dry mouth or sluggish digestion. None of these trials were designed specifically around dementia or Parkinson’s disease, but better digestion and comfort can indirectly help brain health by supporting nutrition and reducing chronic distress. Ginger is also immune supportive, particularly with Th1/Th2 balance.

Sage, particularly Salvia officinalis, has a more direct neuro story. A double blind, placebo-controlled trial in people with mild to moderate Alzheimer’s disease found that sage extract improved cognitive scores and reduced agitation over four months compared with placebo (Akhondzadeh et al., 2003). Other small trials in healthy adults have shown acute improvements in attention and memory after sage based formulations (Perry et al., 2018). Sage tea is less standardised than the extracts used in these studies, but the overall message is that sage is one of the few culinary herbs with early human data suggesting potential cognitive benefits.

Peppermint has one of the strongest track records in herbal gastroenterology. Meta analyses of enteric coated peppermint oil show clear benefit for global irritable bowel syndrome symptoms and abdominal pain compared with placebo (Khanna et al., 2014; Alammar et al., 2019). Peppermint tea is less concentrated, but many people find it soothing for bloating and mild cramps. Because peppermint can relax the lower oesophageal sphincter, it may worsen reflux in some, which is worth remembering if someone already has heartburn.

Put together, blends like rooibos with ginger and lemon for calming and inflammation, green tea for calm focus via L theanine, peppermint for tummy issues and ginger with sage for saliva and throat comfort make mechanistic sense. The honest caveat is that the direct neurodegeneration data for these combinations in humans is almost non existent. They are best seen as supportive rituals that can improve comfort, stress levels and digestion around a broader neuroprotective pattern, not as stand alone dementia treatments.

So what do you actually do with all of this?

The temptation after reading a dense evidence review is to look for the single rule. Two coffees: good. Four coffees: bad. Green tea: miracle. Black tea: maybe. Rooibos: a nice extra.

Reality is more human, more boring and more powerful than that.

Here is the most balanced message the science supports right now.

Regular tea and coffee consumption, especially green tea, matcha and filtered coffee in low to moderate amounts, is consistently associated with lower risk of dementia and Parkinson’s disease in large human studies, while ALS/MND risk seems mostly unaffected (Jiang et al., 2023; Zhang et al., 2021; Zhu et al., 2024; Costa et al., 2010; Fitzgerald et al., 2014; Fondell et al., 2015). The likely brain active players are caffeine, chlorogenic acids and catechins like EGCG, plus L theanine in tea, all of which have plausible neuroprotective mechanisms and encouraging early human data (Pervin et al., 2018; Islam et al., 2025; Johal et al., 2024; Owen et al., 2008; Kahathuduwa et al., 2020).

At the same time, almost all of these data are observational. They show patterns and probabilities, not guarantees. They do not override your lived experience.

If coffee makes your chest pound, your thoughts race, your sleep fragment or your digestion miserable, your nervous system is telling you something meaningful. That is exactly when it makes sense to slide your personal dial toward fewer coffees, earlier coffees, more green tea and matcha, and more caffeine free herbal blends later in the day.

If your ferritin is low or you have a history of iron deficiency, spacing your tea, coffee and matcha at least one hour away from iron rich meals and supplements is a simple way to keep the ritual and protect your iron.

If you know you carry a catechol-O-methyltransferase (COMT), variant associated with slower breakdown of dopamine and noradrenaline, or you simply recognise yourself in the “wired but tired” description, then your safest caffeine window is likely smaller. You may do better with one carefully timed coffee and some green tea than with several strong coffees spread through the day.

If, on the other hand, you are one of the people who can drink a couple of filtered coffees and several cups of tea, sleep soundly, feel calm and keep your blood pressure and cholesterol under control, current evidence suggests that your daily brew is not only safe, it may well be one of the small, repeated choices that helps your brain stay itself for longer.

The real art is not in copying someone else’s mug, but in learning how your brain, your gut, your sleep and your genes respond, then using the science as a map rather than a prison.

How you Nutrition Clinic can help

All of this science becomes powerful only when it becomes personal.

Because the truth is, no population study knows your nervous system. No meta-analysis knows how you sleep after coffee, how your digestion reacts to green tea, or whether your genes make caffeine feel like rocket fuel or like panic.

That’s where we step in.

At You Nutrition Clinic, we help you translate this research into something that actually fits your life, your biology and your future brain. For some clients, that means exploring nutrigenomic testing - genes such as catechol-O-methyltransferase (COMT), apolipoprotein-E (APOE) and cytochrome P450 1A2 (CYP1A2), which influence how the body responds to caffeine, plant compounds and oxidative stress.

For others, it means understanding how tea and coffee timing affects iron stores, gut comfort, sleep cycles or anxiety patterns - the things the scientific papers don’t see but your body absolutely feels.

We don’t hand out rigid diets or universal rules. We help you build a way of eating and living that works with your physiology, not against it.

Small daily rituals can become powerful long-term tools. And your morning mug - once just a habit - can become part of a strategy to support long-term cognitive wellbeing.

If you want to understand your own neuroprotective pattern, decode your genetics, or build a personalised plan that respects your nervous system, we’re here to guide you.

Your brain is worth protecting. And your daily brew is a surprisingly good place to start.

💬 Stay Connected

If you’d like to explore evidence-based nutrition strategies to support brain health, oxidative balance, and healthy ageing, contact You Nutrition Clinic to speak with one of our practitioners.

🧩 Connect with us

For research updates, practical tips, and ongoing inspiration, follow us on Instagram:

👉 @nutritionandthebrain

Stay curious. Stay hopeful. Support your brain. 🧠

References

Abbel, D., Åsvold, B. O., Kolberg, M., Langballe, E. M., Vatten, L. J., Wilsgaard, T., & Thingstad, P. (2023). The association between coffee and tea consumption at midlife and risk of dementia later in life: The HUNT Study. Nutrients, 15(11), 2469.

Akhondzadeh, S., Noroozian, M., Mohammadi, M., Ohadinia, S., Jamshidi, A. H., & Khani, M. (2003). Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomized and placebo controlled trial. Journal of Clinical Pharmacy and Therapeutics, 28(1), 53–59.

Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., & Shinohara, R. T. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data. BMC Complementary and Alternative Medicine, 19, 21.

Ali, N., Alhakamy, N. A., Hammouda, S., & El-Saeed, S. (2023). Microplastic release from commercial tea bags during brewing: Characterisation and human health risk assessment. Environmental Science and Pollution Research, 30, 67452–67463.

Aregawi, L. G., Shokrolahi, F., & Gebremeskel, G. G. (2023). The effect of ginger supplementation on the improvement of dyspeptic symptoms in patients with functional dyspepsia. Cureus, 15(9), e45272.

Banaei, M., Golgoli, M., & Jannat, B. (2024). Release of microplastics from nylon and PET tea bags into brewed tea: A comparative analysis. Food Additives & Contaminants: Part A, 41(3), 521–533.

Cendrowski, A., Gładysz, O., & Żyżelewicz, D. (2023). Polyphenol composition, antioxidant activity and potential health applications of Cistus incanus: An updated review. Molecules, 28(14), 5562.

Chen, J. Q. A., Scheltens, P., Groot, C., & Ossenkoppele, R. (2020). Associations between caffeine consumption, cognitive decline, and dementia: A systematic review. Journal of Alzheimer’s Disease, 78(4), 1519–1546.

Costa, J., Lunet, N., Santos, C., Santos, J., & Vaz-Carneiro, A. (2010). Caffeine exposure and the risk of Parkinson’s disease: A systematic review and meta-analysis of observational studies. Journal of Alzheimer’s Disease, 20(Suppl. 1), S221–S238.

Djavaheri-Mergny, M., Boulahbel, H., & De Miremont, R. (2025). Polyphenols from Cistus species: Autophagy modulation, inflammation control and potential neuroprotective pathways. Journal of Herbal Medicine, 45, 101–112.

Drake, C. L., Roehrs, T., Shambroom, J., & Roth, T. (2013). Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. Journal of Clinical Sleep Medicine, 9(11), 1195–1200.

Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009). Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study. Journal of Alzheimer’s Disease, 16(1), 85–91.

Fitzgerald, K. C., O’Reilly, É. J., Fondell, E., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., Ascherio, A., & Freedman, N. D. (2014). Coffee, tea, and caffeine consumption and risk of amyotrophic lateral sclerosis. European Journal of Neurology, 21(12), 1355–1361.

Fondell, E., O’Reilly, É. J., Fitzgerald, K. C., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., Ascherio, A., & Freedman, N. D. (2015). Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(1–2), 90–98.

Fuzi, S. F. N., Koller, D., Bruggraber, S., Pereira, D. I. A., & Sharp, P. A. (2017). Interactions of tea and coffee with iron absorption. Nutrients, 9(5), 1116.

Giacosa, A., Guido, D., Grassi, M., Riva, A., Morazzoni, P., Bombardelli, E., & Rondanelli, M. (2015). The effect of ginger and artichoke extract supplementation on functional dyspepsia: A randomized controlled trial. Evidence-Based Complementary and Alternative Medicine, 2015, 915087.

Grosso, G., Godos, J., Galvano, F., Giovannucci, E. L., & Lafranconi, A. (2017). Coffee, caffeine, and health outcomes: An umbrella review. Annual Review of Nutrition, 37, 131–156.

Hernandez, L. M., Xu, E. G., Larsson, H. C. E., Tahara, R., Maisuria, V. B., & Tufenkji, N. (2019). Plastic teabags release billions of microparticles and nanoparticles into tea. Environmental Science & Technology, 53(21), 12300–12310.

Hong, C. T., Chan, L., & Bai, C.-H. (2020). The effect of caffeine on risk and progression of Parkinson’s disease: A meta-analysis. Nutrients, 12(6), 1860.

Hu, C., Zhang, J., Li, W., Luo, M., & Wang, R. (2023). Current status and health risk assessment of heavy metals contamination in tea across China. International Journal of Environmental Research and Public Health, 20(15), 6436.

Hu, H.-Y., Wu, B.-S., Zhao, Q.-H., Wang, M., & Yu, J.-T. (2022). Tea consumption and risk of incident dementia: A prospective cohort study of UK Biobank participants. Translational Psychiatry, 12, 178.

Hurrell, R. F., Reddy, M. B., Juillerat, M. A., & Cook, J. D. (1999). Degradation of phytic acid improves iron absorption by human subjects. American Journal of Clinical Nutrition, 70(4), 536–541.

Huin, V., Vaugoyeau, M., & Camu, W. (2024). Caffeine consumption outcomes on amyotrophic lateral sclerosis: A review of current evidence. Neurotoxicology, 95, 120–131.

Islam, M. A., Tabassum, N., Lee, S., & Yoon, J. (2025). Neuroprotective insights into EGCG in neurodegenerative diseases. Exploration of Neuroscience, 4, 100673.

Jiang, W., Wang, X., Liu, F., & Zhang, H. (2023). Tea consumption and dementia risk: A systematic review and dose–response meta-analysis. Ageing Research Reviews, 87, 101934.

Johal, K., Jin, Y., & Dore, G. (2024). Coffee-derived chlorogenic acids and cognition: A systematic review. Nutrients, 16(2), 412.

Kahathuduwa, C. N., Dassanayake, T. L., Amarakoon, A. M. T., & Weerasinghe, V. S. (2020). The effects of theanine, caffeine, and their combination on cognition and mood. Nutrition Reviews, 78(10), 760–775.

Kandinov, B., Giladi, N., & Korczyn, A. D. (2009). Smoking and tea consumption delay onset of Parkinson’s disease. Parkinsonism & Related Disorders, 15(1), 41–46.

Khan, M. A., Awan, S. A., & Malik, A. (2024). Aluminium and heavy metal accumulation in tea leaves: Exposure risks and neurodegenerative links. Toxicology Reports, 11, 155–172.

Khanna, R., MacDonald, J. K., & Levesque, B. G. (2014). Peppermint oil for irritable bowel syndrome: A meta-analysis. Journal of Clinical Gastroenterology, 48(6), 505–512.

Kurita, N., Otsuka, R., Kato, Y., Nishita, Y., Tange, C., Tomida, M., Ando, F., & Shimokata, H. (2020). Green tea, matcha and cognitive function in older adults. Nutrients, 12(6), 1787.

Lee, J. Y., Sung, J., Kim, Y. S., & Park, J. (2023). Coffee intake and risk of irritable bowel syndrome: A meta-analysis. Nutrients, 15(22), 4745.

Li, G., Ma, C., Zhang, Z., & Zheng, W. (2012). Caffeine intake and Parkinson’s disease: A dose response meta-analysis. European Journal of Epidemiology, 27(2), 89–98.

Livingston, G., Huntley, J., Sommerlad, A., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446. https://doi.org/10.1016/S0140-6736(20)30367-6

Liu, Q. P., Wu, Y. F., Cheng, H. Y., Xia, T., Ding, H., Wang, H., & Xu, Y. (2016). Habitual coffee consumption and cognitive decline: A systematic review. Nutrition, 32(6), 628–636.

Liu, X., Guo, J., & Zhang, K. (2024). Caffeine consumption and anxiety: A dose–response meta-analysis. Journal of Affective Disorders, 351, 271–283.

Nila, I. S., Villagra Moran, V. M., Khan, Z. A., & Hong, Y. (2023). Daily coffee and Alzheimer’s disease risk: A systematic review. Journal of Lifestyle Medicine, 13(2), 83–89.

Oniszczuk, T., Oniszczuk, A., Wójcik, M., Waksmundzka-Hajnos, M., & Głowniak, K. (2023).

Phytochemicals, antioxidant activity and health-related properties of Cistus incanus: New insights from recent analytical studies. Antioxidants, 12(1), 113.

Owen, G. N., Parnell, H., De Bruin, E. A., & Rycroft, J. A. (2008). The combined effects of L-theanine and caffeine on cognitive performance. Nutritional Neuroscience, 11(4), 193–198.

Perry, N. S. L., Houghton, P. J., & Howes, M.-J. R. (2018). A randomised placebo-controlled pilot trial of sage, rosemary and Melissa extract on cognition. Phytotherapy Research, 32(1), 161–170.

Pervin, M., Unno, K., Ohishi, T., Tanabe, H., Miyoshi, N., & Nakamura, Y. (2018). Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules, 23(6), 1297.

Saji, N., Kaise, R., Shimizu, H., Kawarai, T., & Kita, Y. (2025). Green tea consumption and dementia risk. Journal of Nutrition, Health & Aging, 29(2), 101–109.

Svatun, Å. L., Løchen, M.-L., Wilsgaard, T., et al. (2022). Association between espresso coffee and serum total cholesterol: The Tromsø Study 2015–2016. Open Heart, 9(1), e001946.

Stein, M. B., Fallin, M. D., Schork, N. J., & Gelernter, J. (2006). COMT polymorphisms and anxiety traits. Neuropsychopharmacology, 31(9), 2092–2102.

Skalska, M., Pietrzak, W., Kropornicka, A., Owczarek, A., Wawer, I., & Kiss, A. K. (2021).

Effects of Cistus incanus herbal tea on oxidative stress markers and lipid profile in healthy adults: A randomized controlled trial. Phytotherapy Research, 35(2), 987–996.

Tan, L. C., Koh, W. P., Yuan, J. M., Wang, R., Au, W. L., Tan, J. H., Tan, E. K., & Yu, M. C. (2008). Black vs green tea and Parkinson’s risk. American Journal of Epidemiology, 167(5), 553–560.

Uchida, S., Kurita, N., Otsuka, R., & Ando, F. (2024). Matcha consumption and cognitive function in older adults. Nutrients, 16(1), 55.

Wikoff, D., Welsh, B. T., Henderson, R., Brorby, G. P., et al. (2017). Systematic review of caffeine safety. Food and Chemical Toxicology, 109, 585–648.

Wnuk, E., Rzemieniec, J., & Stępień, A. E. (2025). Antioxidant potential of black tea polyphenols in heavy metal toxicity. International Journal of Molecular Sciences, 26(4), 4152.

Yaroslavov, A. A., Bondarenko, L. S., & Polyakova, A. V. (2025). Nanoplastic shedding from polymer tea bags during steeping. Journal of Hazardous Materials, 480, 133704.

Yousefi, M., Mahdavi, V., & Esfandiari, A. (2024). Human health risk assessment of microplastics released from tea bags. Science of the Total Environment, 912, 168504.

Zhang, J., Yang, X., Lin, Y., Chen, Y., & Zhou, R. (2021). Coffee and tea consumption and dementia risk: UK Biobank. PLOS Medicine, 18(11), e1003830.

Zhu, G., Yin, X., Xin, Y., & Liu, Z. (2024). Coffee consumption and Alzheimer’s disease: A dose–response meta-analysis. Nutrients, 16(5), 1023.